Compounded medications are formulated in state-licensed and FDA-registered facilities based on a providers prescription for an individual patient
GHK-Cu cannot
The outcomes described in this publication represent possibilities rather than guarantees, and some individuals may experience minimal noticeable benefits despite appropriate use
Hepatic lipid accumulation is strongly correlated with this metabolic problem, which may worsen PCOS progression by interfering with FXR/TGR5 dual-receptor signaling (Ma et al., 2025)
BPC-157/TB-500/GHK-Cu 10+10+50mg (GLOW blend 70mg) $200.00 Volume discounts Auto-applied at checkout Free shipping on orders of $200+ Compound Identity COMPOUND NAME BPC+TB500+GHK-Cu SYNONYMS GLOW blend CAS NUMBER 137525-51-0 (BPC-157), 77591-33-4 (TB500), 300801-03-0 (GHK-Cu) MOLECULAR FORMULA C 62 H 98 N 16 O 22 (BPC-157), C 212 H 350 N 56 O 78 S (TB500), C 28 H 46 CuN 12 O 8 (GHK-Cu) MOLECULAR WEIGHT ~6786.95 g/mol STRUCTURE Multi-peptide blend PEPTIDE SEQUENCE Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (BPC-157), Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (TB500), Gly-His-Lys (GHK-Cu) CHEMICAL STRUCTURE Molecular Formula : C 62 H 98 N 16 O 22 (BPC-157), C 212 H 350 N 56 O 78 S (TB500), C 28 H 46 CuN 12 O 8 (GHK-Cu) Source: PubChem Mechanism of Action GLOW blend works through multiple complementary biological pathways that promote tissue repair, regeneration, and inflammation control
